• Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
  • Log In
    • Register
Contacts us @ MediPr.org
Medical News Asia | Powered by ['mediPr]
  • MDnews
  • About [‘mediPr]
  • HER2 Explorer
  • TROP Tool
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Dr Ho SO – Vaccination Safety and Effectiveness in Immunocompromised Patients

HKMA CME Live Lecture: Dr Ho SO – Vaccination Safety and Effectiveness in Immunocompromised Patients

26 August 2022/Enter your password to view comments./in COVID-19, SARS-CoV2, Infectious Disease/by Coco Chong

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2022/08/Dr-Ho-SO-–-Vaccination-Safety-and-Effectiveness-in-Immunocompromised-Patients.jpg 1024 1918 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2022-08-26 05:25:062022-09-19 11:29:45HKMA CME Live Lecture: Dr Ho SO – Vaccination Safety and Effectiveness in Immunocompromised Patients
Vaccination versus Active Infection_A Comparison of the Cardiovascular Risks

Vaccination versus Active Infection: A Comparison of the Cardiovascular Risks

26 August 2022/0 Comments/in COVID-19, SARS-CoV2, Cardiovascular, Infectious Disease/by Christy Leung

Inflammation and homeostasis disruption, from either coronavirus disease 2019 (COVID-19) infection and vaccination, can give rise to cardiovascular pathology.

Read more
https://medi-paper.com/wp-content/uploads/2022/08/Vaccination-versus-Active-Infection_A-Comparison-of-the-Cardiovascular-Risks.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-08-26 03:30:452022-08-30 10:51:31Vaccination versus Active Infection: A Comparison of the Cardiovascular Risks
Common Respiratory Viruses and Their Associated Cardiovascular Risks

Common Respiratory Viruses and Their Associated Cardiovascular Risks

26 August 2022/0 Comments/in COVID-19, SARS-CoV2, Cardiovascular, Infectious Disease/by Christy Leung

Influenza types A and B, respiratory syncytial virus (RSV), adenovirus, and parainfluenza virus types 1, 2, 3 have long been categorised as the common respiratory viruses in Hong Kong.

Read more
https://medi-paper.com/wp-content/uploads/2022/08/Common-Respiratory-Viruses-and-Their-Associated-Cardiovascular-Risks.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-08-26 02:02:012022-08-30 10:51:35Common Respiratory Viruses and Their Associated Cardiovascular Risks
Strategy for COVID-19 vaccination: Disease control, elimination or eradication

Strategy for COVID-19 vaccination: Disease control, elimination or eradication?

12 July 2022/Enter your password to view comments./in COVID-19, SARS-CoV2, Infectious Disease/by Kathlin Ambrose

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2022/07/Strategy-for-COVID-19-vaccination-Disease-control-elimination-or-eradication.jpg 1024 1918 Kathlin Ambrose https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kathlin Ambrose2022-07-12 07:00:302022-07-13 05:40:30Strategy for COVID-19 vaccination: Disease control, elimination or eradication?
SARS-CoV-2 evolution in the COVID-19 era: Three years and counting

SARS-CoV-2 evolution in the COVID-19 era: Three years and counting

8 July 2022/0 Comments/in COVID-19, SARS-CoV2, Infectious Disease/by Christy Leung

Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, was declared a pandemic by the World Health Organisation on 11th March, 2020, as justified by the virus’ uncontrollable, international spread.

Read more
https://medi-paper.com/wp-content/uploads/2022/07/SARS-CoV-2-evolution-in-the-COVID-19-era-Three-years-and-counting.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-07-08 08:39:322022-07-12 09:20:40SARS-CoV-2 evolution in the COVID-19 era: Three years and counting
UK statistics suggest COVID-19 variant types as “long COVID” progression predictors

UK statistics suggest COVID-19 variant types as “long COVID” progression predictors

8 July 2022/0 Comments/in COVID-19, SARS-CoV2, Infectious Disease/by Christy Leung

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. As its name suggests, SARS-CoV-2 primarily targets at hosts’ respiratory tracts.

Read more
https://medi-paper.com/wp-content/uploads/2022/07/UK-statistics-suggest-COVID-19-variant-types-as-long-COVID-progression-predictors.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-07-08 08:01:272022-07-12 09:10:35UK statistics suggest COVID-19 variant types as “long COVID” progression predictors
COVID-19 ANTIVIRAL TREATMENT AND BOOSTER VACCINE EFFECTIVENESS

COVID-19 Antiviral Treatment and Booster Vaccine Effectiveness

21 June 2022/Enter your password to view comments./in COVID-19, Infectious Disease/by Kathlin Ambrose

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2022/06/MPR-FOS-2022003_1918x1024.jpg 1024 1918 Kathlin Ambrose https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kathlin Ambrose2022-06-21 02:46:572022-07-13 05:48:31COVID-19 Antiviral Treatment and Booster Vaccine Effectiveness
Feasibility of Implementing Population-Wide Opt-Out HIV Testing Scheme

Feasibility of Implementing Population-Wide Opt-Out HIV Testing Scheme

20 June 2022/0 Comments/in COVID-19, SARS-CoV2, AIDS, Infectious Disease, HIV/by Christy Leung

Microorganisms are omnipresent, yet most of us do not get infected easily. Patients who are infected with the human immunodeficiency virus (HIV), however, are an exception. This can be attributed to host immunosuppression caused by the virus.

Read more
https://medi-paper.com/wp-content/uploads/2022/06/HIV-cover-photo.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-06-20 07:49:562022-06-28 11:33:57Feasibility of Implementing Population-Wide Opt-Out HIV Testing Scheme
An Overview of the South African COVID-19 Subvariant Outbreak: How Serious is It?

An Overview of the South African COVID-19 Subvariant Outbreak

17 June 2022/0 Comments/in COVID-19, SARS-CoV2, Infectious Disease/by Christy Leung

The first reported case of Coronavirus Disease 2019 (COVID-19) was reported in China on 17th November, 2019. The disease is caused by SARS-CoV-2 virus, and the circulating strains have varied periodically since the outbreak, beginning with the wild-type strain. The Alpha and Delta variants appeared in late 2020, while the Omicron variant appeared in November 2021.

Read more
https://medi-paper.com/wp-content/uploads/2022/06/cover-photo-1918x1024-1.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-06-17 02:30:592022-06-28 11:55:35An Overview of the South African COVID-19 Subvariant Outbreak
COVID-19 Vaccinations in Adolescents and Children

COVID-19 Vaccinations in Adolescents and Children

30 May 2022/Enter your password to view comments./in COVID-19, SARS-CoV2, Paediatrics, Infectious Disease/by Connie TANG

There is no excerpt because this is a protected post.

Read more
https://medi-paper.com/wp-content/uploads/2022/05/COVID-19-Vaccinations-in-Adolescents-and-Children-scaled.jpg 1367 2560 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-05-30 07:01:232022-07-13 05:54:09COVID-19 Vaccinations in Adolescents and Children
Page 2 of 7‹1234›»

Categories

Categories

Newsletter


 [‘mediPr] | MediPaper Healthcare Writers | Digital Medical Marketing | Medical Writing Solutions 醫學寫作 | Medical Writing Quote | Medical Writing Portfolio | Medical Writer Hong Kong 醫學作家香港 | Hire Healthcare Writers Hong Kong | Contact our Medical Writer Agency | MediPaper Health News | CORTiX AI for Medical Science | Dub-Dub Subtitle Generation
© 2016-2026 MediPaper Medical Communications Ltd. | Website by [’mediPr] Sydney | Singapore | Hong Kong | 醫學作家香港 | Privacy Policy | Cookie Policy
  • Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
Scroll to top Scroll to top Scroll to top

This site uses cookies to improve your experience. By continuing to browse the site, you are agreeing to our use of cookies.

OKPrivacy Settings×

Cookies and Privacy on medi-paper.com



Cookie Policy

How MediPaper uses cookies is explained in our Cookie Policy

Privacy Policy

Read MediPaper's Privacy Policy

Google Analytics cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

5
Accept settingsHide notification only